TY - JOUR
T1 - Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection
T2 - A real-world perspective and review of the literature
AU - Babiker, Ahmed
AU - Clarke, Lloyd
AU - Doi, Yohei
AU - Shields, Ryan K.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/11
Y1 - 2019/11
N2 - Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.
AB - Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.
UR - http://www.scopus.com/inward/record.url?scp=85068776483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068776483&partnerID=8YFLogxK
U2 - 10.1016/j.diagmicrobio.2019.06.008
DO - 10.1016/j.diagmicrobio.2019.06.008
M3 - Article
C2 - 31307867
AN - SCOPUS:85068776483
SN - 0732-8893
VL - 95
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
IS - 3
M1 - 114856
ER -
